Illness	Number of cases
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	154
Malignant neoplasm of bronchus and lung (C34.3)	122
Malignant neoplasm of rectum (C20)	120
Malignant neoplasm of bronchus and lung (C34.1)	120
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	101
Malignant neoplasm of ovary (C56)	79
Malignant neoplasm of breast (C50.9)	75
Non-follicular lymphoma (C83.3)	70
Malignant neoplasm of colon - Malignant neoplasm of sigmoid colon (C18.7)	69
Malignant neoplasm of bronchus and lung (C34.9)	57

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	704
(9-984.b)	589
(9-984.7)	497
(9-984.8)	455
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.32)	356
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	336
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	323
Anaesthesia with administration of an anaesthetic into a vein (8-900)	277
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	269
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	239

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500 , 3752

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	1

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
167	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Editors of scientific journals/textbooks
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB20	Nursing professional B. Sc.
HB17	Auxiliary nurse (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)